Skip to content
The BCI Briefing

Patent familyBCI, high confidence

Implantable nerve electrode and method for producing an implantable nerve electrode

Filed by CorTec and Albert-ludwigs-universitaet Freiburg, first in 2011.

Granted · CN, DE, EP, USView in Espacenet
Earliest priority
11 Jul 2011 · Germany
Status
A grant was published in China, Germany, European Patent Office, United States, first on 12 Feb 2015
Published in
Germany · International (PCT) · United States · China · European Patent Office
Registered as
CORTEC GMBH
Inventors
Schüttler, Martin · Kohler, Fabian · Schuettler, Martin · Schuettler, Martin, Dr.-Ing. · Schüttler, Martin, Dr.-Ing. · Köhler, Fabian
Family
DOCDB 46578997 · 11 publications

What it concerns

The invention relates to an implantable nerve electrode (1) that comprises an electrically insulating substrate (2) with conductor traces (3) running therein, electrode contacts (4) and connection contacts (5), wherein the conductor traces (3) connect the electrode contacts (4) to the connection contacts (5), and wherein the electrode contacts (4) can be connected to the nerves of a nervous system, each of the conductor traces (3) having an at least partial sheathing (13) made of a polymer that is mechanically strong and a good insulator. The invention further relates to a method for producing an implantable nerve electrode (1).

The abstract as published by the patent office, from US2014128954A1. It describes the invention; it is not a statement of what is protected.

Protection themes

  • Interface and electrodes

    Electrodes and arrays · Peripheral interfaces

  • Packaging

    Connectors and feedthroughs

  • Stimulation

    Stimulation

What the filing appears to be about, read by published rules from its title, abstract and classification codes (A61N1/0551, A61N1/0553, H01R43/16, Y10T29/49224). The claims define what a patent protects, and they are not read here.

Why it matters

Interface and electrodes
Everything downstream works with what the contacts pick up. Their number, size and distance from the neurons set the ceiling on the signal. The problem behind it: more contacts, closer to neurons, that still record after years in tissue that reacts to them.
Packaging
Body fluid destroys unprotected electronics. An implant meant to last has to stay sealed for years while passing every channel through its wall. The problem behind it: a seal that lasts as long as the patient needs it, at a size that leaves room for the channels.
Stimulation
Restoring sensation, sight or movement needs information going in, and a therapy that adapts needs to sense and stimulate at once. The problem behind it: evoking a precise, stable effect without damaging tissue or electrodes, and without blinding the recording.

Why the layer matters to the field, not a judgement of this filing. A patent family shows that protection was sought. It does not show that the technology was built, is used in a product, or works in people. The whole stack

The family

One invention, published 11 times in 5 offices. Each publication opens in Espacenet.

Timeline

  1. 11 Jul 2011First filingEarliest priority, at Germany. The family is counted in this year.
  2. 10 Jul 2012ApplicationsFiled at International (PCT), China, European Patent Office.
  3. 17 Jan 2013First publicationDE102011078982A1, Germany.
  4. 6 Jun 2013Owner recordedGermany, on DE102011078982A1: change of applicant/patentee; owner named: CORTEC GMBH, DE.
  5. 10 Jan 2014ApplicationFiled at United States.
  6. 19 Feb 2014Owner recordedUnited States, on US2014128954A1: assignment; owner named: CORTEC GMBH, GERMANY.
  7. 12 Feb 2015Grant publishedDE102011078982B4, Germany.
  8. 13 Apr 2016Grant publishedCN103813828B, China.
  9. 22 Mar 2017Grant publishedEP2731669B1, European Patent Office.
  10. 17 Jul 2018ApplicationFiled at United States.
  11. 1 Apr 2019Owner recordedEuropean Patent Office, on EP2731669A1: reference to a national code; owner named: CORTEC GMBH, DE.
  12. 22 Jun 2021Grant publishedUS11040193B2, United States.
  13. 31 Jul 2024Office recordEuropean Patent Office, on EP2731669A1: lapsed in a contracting state [announced via postgrant information from national office to epo] (AL, AT, BE, BG, CH, CY, CZ, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).
  14. 3 Feb 2026Office recordGermany, on DE102011078982A1: application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee.

Dates as the offices published them. Office records are in the offices' own words and are a selection: refusals, lapses and withdrawals, and records that name an owner. Each concerns one member of the family, not the family as a whole, and another member in the same office may stand. Whether a patent is in force today is not assessed.

Sources

  • Bibliographic data, family members and office records: European Patent Office, Open Patent Services (the DOCDB and INPADOC databases), read 7 Oct 2026.
  • The record itself, with its claims and description: US2014128954A1 in Espacenet
  • Counted as a BCI patent family: classified A61N1/36 (electrical stimulation therapy); filed by CORTEC GMBH, an organisation already in the graph; describes neural hardware or methods without naming the field; cites a family already accepted. How families are found and judged